[Clinical aspects and therapy of shigellosis in childhood].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000992:Antitoxins / Q000627:therapeutic use; D002648:Child; D004405:Dysentery, Bacillary / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D005260:Female; D005664:Furazolidone / Q000627:therapeutic use; D005859:Germany, East; D006801:Humans; D007223:Infant; D008297:Male; D009355:Neomycin / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000992:Antitoxins; D011113:Polymyxins; D013449:Sulfonamides; D005664:Furazolidone; D009355:Neomycin
Klinik und Therapie der Shigellosen im Kindesalter.